01046 Relative Valuation
01046's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, 01046 is overvalued; if below, it's undervalued.
Historical Valuation
UNIVERSE ENT (01046) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of UNIVERSE ENT (01046) is between -- to -- according to relative valuation methord.
Relative Value
Fair Zone
-----
Current Price：0.42
Fair
0.00
PE
1Y
3Y
5Y
0.00
EV/EBITDA
UNIVERSE ENT. (01046) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.
0.00
EV/EBIT
UNIVERSE ENT. (01046) has a current EV/EBIT of 0.00. The 5-year average EV/EBIT is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBIT of 0.00 falls within the Strongly Undervalued range.
0.00
PS
UNIVERSE ENT. (01046) has a current PS of 0.00. The 5-year average PS is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward PS of 0.00 falls within the Strongly Undervalued range.
0.00
P/OCF
UNIVERSE ENT. (01046) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/OCF of 0.00 falls within the Strongly Undervalued range.
0.00
P/FCF
UNIVERSE ENT. (01046) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.
UNIVERSE ENT (01046) has a current Price-to-Book (P/B) ratio of 1.62. Compared to its 3-year average P/B ratio of 1.15 , the current P/B ratio is approximately 40.07% higher. Relative to its 5-year average P/B ratio of 1.11, the current P/B ratio is about 45.64% higher. UNIVERSE ENT (01046) has a Forward Free Cash Flow (FCF) yield of approximately 7.93%. Compared to its 3-year average FCF yield of 9.09%, the current FCF yield is approximately -12.74% lower. Relative to its 5-year average FCF yield of 34.09% , the current FCF yield is about -76.72% lower.
1.62
P/B
Median3y
1.15
Median5y
1.11
7.93
FCF Yield
Median3y
9.09
Median5y
34.09
Performance Decomposition
1Y
3Y
5Y
Market capitalization of 01046 increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of 01046 in the past 1 year is driven by Unknown.
People Also Watch
XOM
Exxon Mobil Corp
122.91USD
3.73%
AMZN
Amazon.com Inc
246.26USD
1.95%
MSFT
Microsoft Corp
478.11USD
-1.11%
META
Meta Platforms Inc
646.06USD
-0.41%
AAPL
Apple Inc
259.04USD
-0.50%
TSLA
Tesla Inc
435.8USD
1.02%
NVDA
NVIDIA Corp
185.04USD
-2.15%
ORCL
Oracle Corp
189.65USD
-1.65%
WMT
Walmart Inc
113.07USD
0.31%
AVGO
Broadcom Inc
332.48USD
-3.21%
Frequently Asked Questions
Is UNIVERSE ENT (01046) currently overvalued or undervalued?
UNIVERSE ENT (01046) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of UNIVERSE ENT (01046) is between to according to relative valuation methord.
What is UNIVERSE ENT (01046) fair value?
01046's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of UNIVERSE ENT (01046) is between to according to relative valuation methord.
How does 01046's valuation metrics compare to the industry average?
The average P/S ratio for 01046's competitors is , providing a benchmark for relative valuation. UNIVERSE ENT Corp (01046) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
What is the current P/B ratio for UNIVERSE ENT (01046) as of Jan 08 2026?
As of Jan 08 2026, UNIVERSE ENT (01046) has a P/B ratio of 1.62. This indicates that the market values 01046 at 1.62 times its book value.
What is the current FCF Yield for UNIVERSE ENT (01046) as of Jan 08 2026?
As of Jan 08 2026, UNIVERSE ENT (01046) has a FCF Yield of 7.93%. This means that for every dollar of UNIVERSE ENT’s market capitalization, the company generates 7.93 cents in free cash flow.
What is the current Forward P/E ratio for UNIVERSE ENT (01046) as of Jan 08 2026?
As of Jan 08 2026, UNIVERSE ENT (01046) has a Forward P/E ratio of 0.00. This means the market is willing to pay $0.00 for every dollar of UNIVERSE ENT’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for UNIVERSE ENT (01046) as of Jan 08 2026?
As of Jan 08 2026, UNIVERSE ENT (01046) has a Forward P/S ratio of 0.00. This means the market is valuing 01046 at $0.00 for every dollar of expected revenue over the next 12 months.